{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T12:32:17Z","timestamp":1779366737749,"version":"3.53.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T00:00:00Z","timestamp":1586736000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Boryung Pharmaceutical Co, Ltd"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.clinthera.2020.03.019","type":"journal-article","created":{"date-parts":[[2020,5,3]],"date-time":"2020-05-03T22:10:50Z","timestamp":1588543850000},"page":"1058-1066.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effectiveness of Fimasartan and Rosuvastatin Combination Treatment in Hypertensive Patients With Dyslipidemia"],"prefix":"10.1016","volume":"42","author":[{"given":"Seung-Jun","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaewon","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Jin","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In-Jeong","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Rae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Sun","family":"Uhm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Young","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyuk-Jae","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chul-Min","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Sun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byeong-Keuk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungha","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Hak","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geu Ru","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Guk","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghoon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2020.03.019_bib1","author":"World Health Organization"},{"key":"10.1016\/j.clinthera.2020.03.019_bib2","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1177\/2047487313497602","article-title":"The Korean Heart Study: rationale, objectives, protocol, and preliminary results for a new prospective cohort study of 430,920 men and women","volume":"21","author":"Jee","year":"2014","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.clinthera.2020.03.019_bib3","first-page":"926","article-title":"Prevalence of comorbid hypertension and dyslipidemia and associated cardiovascular disease","volume":"10","author":"Johnson","year":"2004","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.clinthera.2020.03.019_bib4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0002-9343(86)90157-9","article-title":"A\u00a0population at risk. Prevalence of high cholesterol levels in hypertensive patients in the Framingham Study","volume":"80","author":"Castelli","year":"1986","journal-title":"Am J Med"},{"key":"10.1016\/j.clinthera.2020.03.019_bib5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2014an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clinthera.2020.03.019_bib6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2147\/IBPC.S3809","article-title":"Impact of dyslipidemia on cardiovascular risk stratification of hypertensive patients and association of lipid profile with other cardiovascular risk factors: results from the ICEBERG study","volume":"1","author":"Kabakci","year":"2008","journal-title":"Integr Blood Press Control"},{"key":"10.1016\/j.clinthera.2020.03.019_bib7","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.amjcard.2006.01.079","article-title":"Prevalence, treatment, and control of combined hypertension and hypercholesterolemia in the United States","volume":"98","author":"Wong","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinthera.2020.03.019_bib8","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ahj.2004.02.003","article-title":"Association between different lipid-lowering treatment strategies and blood pressure control in the Brisighella Heart Study","volume":"148","author":"Borghi","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.clinthera.2020.03.019_bib9","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.amjhyper.2004.02.002","article-title":"Pravastatin has an additional depressor effect in patients undergoing long-term treatment with antihypertensive drugs","volume":"17","author":"Ikeda","year":"2004","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.clinthera.2020.03.019_bib10","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1161\/01.HYP.34.6.1281","article-title":"Effect of the HMG-CoA reductase inhibitors on blood pressure in patients with essential hypertension and primary hypercholesterolemia","volume":"34","author":"Glorioso","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.clinthera.2020.03.019_bib11","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1161\/01.HYP.0000259737.43916.42","article-title":"Do statins reduce blood pressure?: a meta-analysis of randomized, controlled trials","volume":"49","author":"Strazzullo","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.clinthera.2020.03.019_bib12","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1001\/archinte.168.7.721","article-title":"Reduction in blood pressure with statins: results from the UCSD Statin Study, a randomized trial","volume":"168","author":"Golomb","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2020.03.019_bib13","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The Seventh report of the Joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2020.03.019_bib14","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"Whelton","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.clinthera.2020.03.019_bib15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40885-019-0124-x","article-title":"2018 Korean Society of Hypertension Guidelines for the management of hypertension: part II-diagnosis and treatment of hypertension","volume":"25","author":"Lee","year":"2019","journal-title":"Clin Hypertens"},{"key":"10.1016\/j.clinthera.2020.03.019_bib16","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American heart association task force on clinical practice guidelines","author":"Grundy","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.clinthera.2020.03.019_bib17","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40360-016-0112-7","article-title":"The efficacy and safety of co-administration of fimasartan and rosuvastatin to patients with hypertension and dyslipidemia","volume":"18","author":"Rhee","year":"2017","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1016\/j.clinthera.2020.03.019_bib18","doi-asserted-by":"crossref","first-page":"36093","DOI":"10.1038\/srep36093","article-title":"Increasing trend of diabetes combined with hypertension or hypercholesterolemia: NHANES data analysis 1999-2012","volume":"6","author":"Song","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.clinthera.2020.03.019_bib19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinthera.2020.03.019_bib20","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1001\/jama.2013.280532","article-title":"Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile","volume":"310","author":"Martin","year":"2013","journal-title":"JAMA"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291820301867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291820301867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:51:55Z","timestamp":1758963115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291820301867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0149291820301867"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2020.03.019","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of Fimasartan and Rosuvastatin Combination Treatment in Hypertensive Patients With Dyslipidemia","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2020.03.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}